Business Description
OPKO Health Inc
NAICS : 339116
SIC : 2835
ISIN : US68375N1037
Description
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.79 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | 27.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.15 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20 | |||||
| 3-Year Book Growth Rate | -10.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.59 | |||||
| 9-Day RSI | 39.61 | |||||
| 14-Day RSI | 43.47 | |||||
| 6-1 Month Momentum % | 22.31 | |||||
| 12-1 Month Momentum % | -1.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | |||||
| Quick Ratio | 2.69 | |||||
| Cash Ratio | 1.92 | |||||
| Days Inventory | 42.96 | |||||
| Days Sales Outstanding | 57.88 | |||||
| Days Payable | 48.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 | |||||
| Shareholder Yield % | -0.75 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.1 | |||||
| Operating Margin % | -43.5 | |||||
| Net Margin % | -18.8 | |||||
| FCF Margin % | -28.11 | |||||
| ROE % | -9.71 | |||||
| ROA % | -6.51 | |||||
| ROIC % | -19.76 | |||||
| ROC (Joel Greenblatt) % | -39.37 | |||||
| ROCE % | -4.39 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.65 | |||||
| PB Ratio | 0.74 | |||||
| Price-to-Tangible-Book | 29.59 | |||||
| EV-to-EBIT | -13.66 | |||||
| EV-to-EBITDA | 58.47 | |||||
| EV-to-Revenue | 1.56 | |||||
| EV-to-Forward-Revenue | 1.64 | |||||
| EV-to-FCF | -5.64 | |||||
| Price-to-Projected-FCF | 5.69 | |||||
| Price-to-Median-PS-Value | 0.89 | |||||
| Earnings Yield (Greenblatt) % | -7.32 | |||||
| FCF Yield % | -19.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OPKO Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 711.408 | ||
| EPS (TTM) ($) | -0.19 | ||
| Beta | 1.48 | ||
| Volatility % | 54.01 | ||
| 14-Day RSI | 43.47 | ||
| 14-Day ATR ($) | 0.064974 | ||
| 20-Day SMA ($) | 1.57143 | ||
| 12-1 Month Momentum % | -1.61 | ||
| 52-Week Range ($) | 0.8516 - 1.7499 | ||
| Shares Outstanding (Mil) | 672.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OPKO Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OPKO Health Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
OPKO Health Inc Frequently Asked Questions
What is OPKO Health Inc(LTS:0KCS)'s stock price today?
The current price of LTS:0KCS is $1.48. The 52 week high of LTS:0KCS is $1.75 and 52 week low is $0.85.
When is next earnings date of OPKO Health Inc(LTS:0KCS)?
The next earnings date of OPKO Health Inc(LTS:0KCS) is 2025-02-27 Est..
Does OPKO Health Inc(LTS:0KCS) pay dividends? If so, how much?
OPKO Health Inc(LTS:0KCS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers